The use of benzodiazepines in the treatment of chest pain: A review of the literature

Journal of Emergency Medicine

Volumn 25, Issue 4, 2003, Pages 427-437

  Huffman, Jeff C ^a,b   Stern, Theodore A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angina; Benzodiazepines; Chest pain; Myocardial infarction; Myocardial ischemia

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE;

ACUTE DISEASE; ADULT; ALGORITHM; ATAXIA; BLOOD; CARDIOVASCULAR EFFECT; CARDIOVASCULAR PERFORMANCE; CARDIOVASCULAR SYSTEM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EMOTIONAL STRESS; ESOPHAGUS ACHALASIA; ESOPHAGUS SPASM; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HUMAN; HYPOTENSION; INJECTION PAIN; INJECTION SITE; MALE; MENTAL DISEASE; MUSCLE FATIGUE; MUSCULOSKELETAL DISEASE; NEUROPATHIC PAIN; PHLEBITIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; THORAX PAIN; VEIN THROMBOSIS;

EID: 0344152222     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2003.01.001     Document Type: Article

References (106)

1. Bahr R.D. The changing paradigm of acute heart attack prevention in the emergency department a futuristic viewpoint? Ann Emerg Med. 25:1995;95-96.
2. The acute coronary syndromes, including myocardial infarction. Cummins R.O. Advanced cardiac life support. 1997;12-22 American Heart Association, Dallas, TX.
3. Fleet R.P., DuPuis G., Marchand A., Burelle D., Arsenault A., Beitman B.D. Panic disorder in emergency chest pain patients prevalence, comorbidity, suicidal ideation, and physician recognition . Am J Med. 101:1996;371-380.
4. Yingling K.W., Wulsin L.R., Arnold L.M., Rouan G.W. Estimated prevalences of panic disorder and depression among consecutive patients seen in an emergency department with acute chest pain. J Gen Intern Med. 8:1993;231-235.
5. Worthington J.J., Pollack M.H., Otto M.W., et al. Panic disorder in emergency ward patients with chest pain. J Nerv Ment Dis. 185:1997;274-276.
6. Storr M., Allescher H.D. Esophageal pharmacology and treatment of primary motility disorders. Dis Esophagus. 12:1999;241-257.
7. Court J.E., Kase C.S. Treatment of tic douloureux with a new anticonvulsant (clonazepam). J Neurol Neurosurg Psychiatry. 39:1976;297-299.
8. Basmajian J.V. Reflex cervical muscle spasm treatment by diazepam, phenobarbital, or placebo . Arch Phys Med Rehabil. 64:1983;121-124.
9. Dixon R.A., Edwards I.R., Pilcher J. Diazepam in immediate post-myocardial infarct period. A double blind trial. Br Heart J. 43:1980;535-540.
10. Melsom M., Andreassen H., Melsom T., Hansen T., Grendahl H., Hillestad L.K. Diazepam in acute myocardial infarction clinical effects and effects on catecholamines, free fatty acids, and cortisol . Br Heart J. 38:1976;804-810.
11. th April.66P-67P.
12. Abel R.M., Reis R.L., Staroscik R.N. Coronary vasodilatation following diazepam (Valium). Br J Pharmacol. 38:1970;620-631.
13. Abel R.M., Reis R.L., Staroscik R.N. The pharmacological basis of coronary and systemic vasodilator actions of diazepam (Valium). Br J Pharmacol. 39:1970;261-274.
14. Ikram H., Rubin A.P., Jewkes R.F. Effect of diazepam of myocardial blood flow of patients with and without coronary artery disease. Br Heart J. 35:1973;626-630.
15. 2 consumption and lactate production during ischemia in dogs . J Cardiothorac Vasc Anesth. 8:1994;302-309.
16. Nitenberg A., Marty J., Blanchet F., Zouioueche S., Baury A., Desmonts J.M. Effects of flunitrazepam on left ventricular pressure, coronary haemodynamics and myocardial metabolism in patients with coronary artery disease. Br J Anaesth. 55:1983;1179-1184.
17. Kornecki E., Ehrlich Y.H., Lenox R.H. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science. 225:1986;1454-1456.
18. Schneider R.A., Zangari B.S. Variation in clotting time, relative viscosity, and other physio-chemical properties of the blood accompanying physical and emotional stress in the normotensive and hypertensive subject. Psychosom Med. 13:1951;289-303.
19. Cristea E., Coeugniet E., Dobrescu D. Action anti-arythmique du diazepam, de la methaqualone et du meprobamate. Poumon Coeur. 26:1970;711-715.
20. Muenster J.J., Rosenberg M.S., Carleton R.A., Graettinger J.S. Comparison between diazepam and sodium thiopental during DC countershock. JAMA. 199:1967;758-760.
21. Papp C. New look at arrhythmias. Br Heart J. 31:1969;267-271.
22. Van Loon G.R. Ventricular arrhythmias treated by diazepam. Can Med Assoc J. 98:1968;785-787.
23. Ballenger J.C. Benzodiazepines. Schatzberg A.F., Nemeroff C.B. The American psychiatric press textbook of psychopharmacology. 1995;215-230 American Psychiatric Press, Washington, DC.
24. Richter J.J. Current theories about the mechanisms of benzodiazepines and neuroleptic drugs. Anesthesiology. 54:1981;66-72.
25. Lader M. Clinical pharmacology of benzodiazepines. Annu Rev Med. 38:1987;19-28.
26. Le Fur G., Mestre M., Carriot T., et al. Pharmacology of peripheral type benzodiazepine receptors in the heart. Prog Clin Biol Res. 192:1985;175-186.
27. Davies L.P., Huston V. Peripheral benzodiazepine binding sites in heart and their interaction with dipyridamole. Eur J Pharmacol. 73:1981;209-211.
28. Mestre M., Carriot T., Belin C., et al. Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sci. 35:1984;953-962.
29. Charbonneau P., Syrota A., Crouzel C., Valois J.M., Prenant C., Crouzel M. Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation. 73:1986;476-483.
30. Taniguchi T., Wang J.K.T., Spector S. 3H-Diazepam binding sites on rat heart and kidney. Biochem Pharmacol. 31:1982;589-590.
31. Mazzone A., Mazzucchelli I., Vezzoli M., et al. Increased expression of peripheral benzodiazepine receptors on leukocytes in silent myocardial ischemia. J Am Coll Cardiol. 36:2000;746-750.
32. Roy-Byrne P.P., Lewis N., Villacres E., Greenblatt D.J., Shader R.I., Veith R.C. Suppression of norepinephrine appearance rate in plasma by diazepam in humans. Life Sci. 43:1988;1615-1623.
33. Hossman V., Maling T.J., Hamilton C.A., Reid J.L., Dollery C.T. Sedative and cardiovascular effects of clonidine and nitrazepam. Clin Pharmacol Ther. 28:1980;167-176.
34. Dionne R.A., Goldstern D.S., Wirdzek P.R. Effects of diazepam premedication and epinephrine-containing local anesthetic on cardiovascular and plasma catecholamine responses to oral surgery. Anesth Analg. 63:1984;640-646.
35. Marty J., Gauzit R., Lefevre P., et al. Effects of diazepam and midazolam on baroreflex control of heart rate and on sympathetic activity in humans. Anesth Analg. 65:1986;113-119.
36. Duka T., Ackenheil M., Noderer J., Doenicke A., Dorow R. Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788. Psychopharmacology (Berl). 90:1986;351-357.
37. Stratton J.R., Halter J.B. Effect of a benzodiazepine (alprazolam) on plasma epinephrine and norepinephrine levels during exercise stress. Am J Cardiol. 56:1985;136-139.
38. Pinto J.M., Kirby D.A., Johnson D.A., Lown B. Diazepam administered prior to coronary artery occlusion increases latency to ventricular fibrillation. Life Sci. 49:1991;587-594.
39. Goldstein D.S., Dionne R., Sweet J., et al. Circulatory, plasma catecholamine, cortisol, lipid, and psychological responses to a real-life stress (third molar extractions) effects of diazepam sedation and of inclusion of epinephrine with the local anesthetic . Psychosom Med. 44:1982;259-262.
40. Mazzuero G., Galdangelo F., Zotti A.M., Bertolotti G., Tarazzi L. Effects of propranolol, atenolol, and chlordesmethyldiazepam on response to mental stress in patients with recent myocardial infarction. Clin Cardiol. 10:1987;293-302.
41. Oswald G.A., Smith C.C.T., Betteridge D.J., Yudkin J.S. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed). 293:1986;917-922.
42. Jewitt D.E., Reid D., Thomas M., Mercer C.J., Valori C., Shillingford J.P. Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction. Lancet. 1:1969;635-641.
43. Siggers D.C., Salter C., Fluck D.C. Serial plasma adrenaline and noradrenaline levels in myocardial infarction using a new double isotope technique. Br Heart J. 33:1971;878-883.
44. Lucchesi B.R., Kniffen F.J. Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system. Circulation. 51:(Suppl 3):1975;241-247.
45. Marty J., Nitenberg A., Blanchet F., Zouioueche S., Desmonts J.M. Effects of midazolam on the coronary circulation in patients with coronary artery disease. Anesthesiology. 64:1986;206-210.
46. Tarnow J., Hess W. Flunitrazepam-pretreatment for prevention of adverse cardiovascular effects following ketamine. Anaesthesist. 28:1979;468-473.
47. Cote P., Noble J., Bourassa M.G. Systemic vasodilatation following diazepam after combined sympathetic and parasympathetic blockade in patients with coronary artery disease. Cathet Cardiovasc Diagn. 2:1976;369-380.
48. Cote P., Campeau L., Bourassa M.G. Therapeutic implications of diazepam in patients with elevated left ventricular filling pressure. Am Heart J. 91:1976;747-751.
49. Messina A.G., Paranicas M., Yao F.S., et al. The effect of midazolam on left ventricular pump performance and contractility in anesthetized patients with coronary artery disease effect of preoperative ejection function . Anesth Analg. 81:1995;793-799.
50. Massaut J., d'Hollander A., Barvais L., Dubois-Primo J. Haemodynamic effects of midazolam in the anaesthetized patient with coronary artery disease. Acta Anaesthesiol Scand. 27:1983;299-302.
51. Nevins M.A., Mattes L.M., Spritzer A.C., Weisenseel A.C., Donoso E., Friedberg C.K. Ineffectiveness of diazepam as an antiarrhythmic agent. J Mt Sinai Hosp N Y. 36:1969;408-414.
52. Spracklen F.H.N., Chambers R.J., Schrire V. Value of diazepam ('Valium') in treatment of cardiac arrhythmias. Br Heart J. 32:1970;827-832.
53. Ikeda T., Doi M., Morita K., Ikeda K. Effects of midazolam and diazepam as premedication of heart rate variability in surgical patients. Br J Anaesth. 73:1994;479-483.
54. Chiou L.C., Chang C.C. Pharmacological relevance of peripheral type benzodiazepine receptors on motor nerve and skeletal muscle. Br J Pharmacol. 12:1994;257-261.
55. Nott M.R., Jameson P.M., Julious S.A. Diazepam for relief of irrigation pain after transurethral resection of the prostate. Eur J Anaesthesiol. 14:1997;197-200.
56. Weber M.B. The treatment of muscle contraction headaches with diazepam. Curr Ther Res Clin Exp. 15:1973;210-216.
57. Torres S.R., Frode T.S., Nardi G.M., et al. Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur J Pharmacol. 408:2000;199-211.
58. Torres S.R., Nardi G.M., Ferrara P., Ribeiro-do-Valle R.M., Farges R.C. Potential role of peripheral benzodiazepine receptors in inflammatory responses. Eur J Pharmacol. 385:1999;R1-2.
59. Zavala F., Taupin V., Descamps-Latscha B. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin-1, tumor necrosis factor, and interleukin-6. J Pharmacol Exp Ther. 255:1990;442-450.
60. Richter J.E., Bradley L.A., Castell D.O. Esophageal chest pain current controversies in pathogenesis, diagnosis, and therapy . Ann Intern Med. 110:1989;66-78.
61. Singh S., Bailey R.T., Stein H.J., DeMeester T.R., Richter J.E. Effect of alprazolam (Xanax) on esophageal motility and acid reflux. Am J Gastroenterol. 87:1992;483-488.
62. Hall J.A., Magne M.L., Twedt D.C. Effect of acepromazine, diazepam, fentanyl-droperidol and oxynorphone on gastroesophageal sphincter pressure in healthy dogs. Am J Vet Res. 48:1987;556-557.
63. Anderson K.O., Dalton C.B., Bradley L.A., Richter J.E. Stress induces alteration of esophageal pressures in healthy volunteers and non-cardiac chest pain patients. Dig Dis Sci. 34:1989;83-91.
64. Smirne S., Scarlato G. Clonazepam in cranial neuralgias. Med J Aust. 1:1977;93-94.
65. Harkins S., Linford J., Cohen J., Kramer T., Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain a double-blind pilot study . J Craniomandib Disord. 5:1991;179-186.
66. Fernandez F., Adams F., Holmes V.F. Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin. J Clin Psychopharmacol. 7:1987;167-169.
67. Dellemijn P.L., Vanneste J.A. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 349:1997;753-758.
68. Sang C.N., Booher S., Gilron I., Parada S., Max M.B. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia efficacy and dose-response trials . Anesthesiology. 96:2002;1053-1061.
69. Max M.B., Schafer S.C., Culnane M., Smoller B., Dubner R., Gracely R.H. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 38:1988;1427-1432.
70. Herman C.R., Schiffman E.L., Look J.O., Rindal D.B. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening a randomized clinical trial . J Orofac Pain. 16:2002;64-70.
71. Aronson P.R. Hyperventilation syndrome a comparative study of the effects of tranquilizers and a sedative upon the electrocardiogram . Clin Pharmacol Ther. 5:1964;553.
72. Jacobs W.F., Battle W.E., Ronan J.A. False-positive ST-T wave changes secondary to hyperventilation and exercise a cineangiographic correlation . Ann Intern Med. 81:1974;479-482.
73. Wasserberger R.H., Siebecker K.L., Lewis W.C. The effect of hyperventilation on the normal adult electrocardiogram. Circulation. 13:1956;850-854.
74. Thompson W.P. The electrocardiogram in the hyperventilation syndrome. Am Heart J. 25:1943;372-373.
75. Scherf D., Schlachman M. The electrocardiographic changes caused by hyperventilation. Am J Med Sci. 213:1947;342-344.
76. rd edn:1994;129-142 Little, Brown, and Company, Boston, MA.
77. Chapman C.R., Feather B.W. Effects of diazepam on human pain tolerance and pain sensitivity. Psychosom Med. 35:1973;330-339.
78. Gracely R.H., McGrath P., Dubner R. Validity and sensitivity of ration scales of sensory and affective verbal pain descriptors manipulation of effect by diazepam . Pain. 5:1978;19-29.
79. Yang J.C., Clark W.C., Ngai S.H., Berkowitz B.A., Spector S. Analgesic action and pharmacokinetics of morphine and diazepam in man an evaluation by sensory decision theory . Anesthesiology. 51:1979;495-502.
80. Hackett T.P., Cassem N.H. Reduction of anxiety in the coronary-care unit. A controlled double-blind comparison of chlordiazepoxide and amobarbital. Curr Ther Res Clin Exp. 14:1972;649-656.
81. Melzack R., Chapman C.R. Psychologic aspects of pain. Postgrad Med. 53:1973;69-75.
82. Bobey M.J., Davidson P.O. Psychological factors affecting pain tolerance. J Psychosom Res. 14:1970;371-376.
83. Merskey H. The nature of pain. Smith W.L., Merskey H., Gross S.C. Pain: meaning and management. 1980;71-74 Spectrum Publications, New York.
84. Volicer B.J. Hospital stress and patient reports of pain and physical status. J Human Stress. 4:1978;28-37.
85. Robin O., Vinard H., Vernet-Maury E., Saumet J.L. Influence of sex and anxiety on pain threshold and tolerance. Funct Neurol. 2:1987;173-179.
86. Clum G.A., Luscomb R.L., Scott L. Relaxation training and cognitive redirection straegies in the treatment of acute pain. Pain. 12:1982;175-183.
87. Janssen S.A., Arntz A., Bouts S. Anxiety and pain epinephrine-induced hyperalgesia and attentional influences . Pain. 76:1998;309-316.
88. Arntz A., de Jong P. Anxiety, attention, and pain. J Psychsom Res. 37:1993;423-432.
89. Arntz A., Dreessen L., Merckelbach H. Attention, not anxiety, influences pain. Behav Res Ther. 29:1991;41-50.
90. Shell W.E., Swan H.J. Treatment of silent myocardial infarction with transdermal nitroglycerin added to beta-blockers and alprazolam. Cardiol Clin. 4:1986;697-704.
91. Mendels J., Chernoff R.W., Blatt M. Alprazolam as an adjunct to propranolol in anxious outpatients with stable angina pectoris. J Clin Psychiatry. 47:1986;8-11.
92. Wheatley D. Coronary heart disease treating the anxiety component . Prog Neuropsychopharmacol. 4:1980;537-544.
93. Wheatley D. Anxiolytic drug use in cardiovascular disease an overview . Psychopharmacol Bull. 20:1984;649-659.
94. Wheatley D. The value of anti-anxiety drugs in the management of cardiac disease. Acta Med Scand Suppl. 660:1982;219-230.
95. Rossetti E., Fragasso G., Xuereb R.G., Xuereb M., Margonato A., Chierchia S.L. Antiischemic effects of intravenous diazepam in patients with coronary artery disease. J Cardiovasc Pharmacol. 24:1994;55-58.
96. Baumann B.M., Perrone J., Hornig S.E., Shofer F.S., Hollander J.E. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med. 7:2000;878-885.
97. Valium. Sifton D. Physicians' desk reference. 2676:2000;3211-3216 Medical Economics Company, Montvale, NJ.
98. Hillestad L., Hansen T., Melsom H., Drivenes A. Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clin Pharmacol Ther. 16:1974;479-484.
99. Hillestad L., Hansen T., Melsom H. Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation. Clin Pharmacol Ther. 16:1974;485-490.
100. Bottiger B.W., Motsch J., Fleischer F., Bauer H., Bohrer H., Martin E. Premedication of coronary risk patients - results of a survey. Anasthesiol Intensivmed Notfallmed Schmerzther. 31:1996;148-154.
101. Raza S.M., Masters R.W., Zsigmond E.K. Comparison of the hemodynamic effects of midazolam and diazepam in patients with coronary occlusion. Int J Clin Pharmacol Ther Toxicol. 27:1989;1-6.
102. Greenblatt D.J., Koch-Weser J. Adverse reactions to intravenous diazepam a report from the Boston Collaborative Drug Surveillance Program . Am J Med Sci. 266:1973;261-266.
103. Vrana M., Hess L., Vranova Z., Fejfar Z. An experimental contribution to the treatment of acute myocardial infarction. Czech Med. 10:1987;142-155.
104. Baris S., Karakaya D., Aykent T., Kirdar K., Sagkan O., Tur A. Comparison of midazolam with or without fentanyl for conscious sedation and hemodynamics in coronary angiography. Can J Cardiol. 173:2001;277-281.
105. Vrana M., Fejfar Z., Hess L., Blazek Z. Analgosedation-enhanced baroreflex sensitivity in acute local myocardial infarction. Cor Vasa. 33:1991;428-434.
106. Hess L., Vrana M., Vranova Z., Fejfar Z. The electrostabilizing effect of a combination of midazolam and fentanyl an experimental study in the dog . Cor Vasa. 31:1989;411-418.